TH-75 blood pressure monitor for detecting atrial fibrillation
Official title: Blood Pressure Monitor (TH-75) Atrial Fibrillation Detection Function Clinical Trial
Run by Andon Health Co., Ltd · NCT07442175 · Data updated 2026-11-12
We will test whether the TH-75 blood pressure monitor can detect atrial fibrillation in adults with or without a prior AF diagnosis.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 22 Years and up |
| Sex | All |
| Enrollment | 392 (estimated) |
| Sponsor | Andon Health Co., Ltd Industry-sponsored |
| Locations | 1 site (Tianjin, Tianjin Municipality) |
| Status | Recruiting |
| Started | February 9, 2026 |
| Main results expected | June 30, 2026 |
| Study ends | July 30, 2026 |
| Registry record updated | March 2, 2026 |
| Trial ID | NCT07442175 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 22 or older with arm circumference 22-42 cm who can cooperate with blood pressure and ECG measurements, whether they have a prior AF diagnosis or not.
✕Probably not a fit
Patients with implanted pacemakers or defibrillators, pregnant people, those with arm circumference outside 22-42 cm, or those unable to cooperate with measurements are unlikely to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study compares readings from the TH-75 blood pressure monitor with a standard diagnostic method (ECG) to measure the device's accuracy for atrial fibrillation detection. Adults aged 22 and older with an arm circumference of 22-42 cm, both people diagnosed with AF and those without known AF, will have simultaneous device and ECG measurements. Participants who are pregnant, have an implanted pacemaker or defibrillator, or cannot cooperate with measurements will be excluded. The trial is conducted at the First Teaching Hospital of Tianjin University of Traditional Chinese Medicine in Tianjin, China.
Why it matters
Potential benefit: If accurate, the TH-75 could enable easier routine blood pressure checks to spot atrial fibrillation sooner and prompt timely care.
How similar studies have gone: Previous studies of blood-pressure devices with AF-detection algorithms have shown promising but variable accuracy, so device-specific testing is needed.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Atrial Fibrillation (AF): * Age ≥ 22 years; * Arm circumference between 22 cm and 42 cm; * Diagnosed with atrial fibrillation by a qualified medical institution. Non-Atrial Fibrillation: * Age ≥ 22 years; * Arm circumference between 22 cm and 42 cm; * No prior diagnosis of atrial fibrillation. Exclusion Criteria: * Pregnant women * Presence of an implanted cardiac pacemaker and/or defibrillator * Inability to cooperate with blood pressure measurement or ECG assessment * Any condition that, in the opinion of the investigator, makes the participant unsuitable for participation in this clinical study
Where it's running
-
First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Tianjin, Tianjin Municipality, China Recruiting
Study contacts
- Study coordinator: Jing Li
- Email: lijing@jiuan.com
- Phone: 022-87611660
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Pulsed Field vs Cryoballoon for Pulmonary Vein Isolation in Atrial Fibrillation
This trial tests whether pulsed field ablation can shorten the procedure for first-time PVI in AF patients compared with cryoballoon ablation, while keeping safety and effectiveness similar.
-
Pulsed Field Ablation vs Cryoablation for Atrial Fibrillation Under Deep Sedation
This trial tests whether pulsed field ablation (PFA) done under deep sedation works as well as cryoballoon ablation for treating atrial fibrillation, aiming to avoid general anesthesia.
-
Bachmann’s Bundle Pacing vs Right Atrial Appendage Pacing for AF
This study tests two common atrial pacing methods to see which one is safer over 12 months for people getting a new pacemaker, ICD, or CRT device.
-
AI-powered ECG to help diagnose and predict outcomes in heart disease
Researchers test an AI-enhanced ECG to help diagnose and predict outcomes for people with cardiovascular diseases.
-
Pace-and-ablate strategy in atrial fibrillation: who benefits and long-term outcomes
This study looks at adults with atrial fibrillation who underwent AV node ablation with permanent pacing to see who develops pacing-induced problems and how they do long-term.
-
AI-based cardiac analysis using 12-lead and 1-lead ECG
A clinician-facing pilot test to see if SmartECG-EF helps evaluate heart function using both 12-lead and single-lead ECGs in adults with heart conditions.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.